AMCIL (AMH) H1 2025 earnings summary

Executive summary

• Half-year profit was $3.6 million, down from $4.1 million year-over-year, mainly due to lower trading and options income.

• Portfolio value increased to $423.1 million from $369.9 million, with outperformance over multiple periods.

• Interim fully franked dividend of 1 cent per share was maintained.

• Shares trade at a discount to NTA ($1.17–$1.175 vs. NTA of $1.33 at December end), reflecting broader industry trends.

• Management is focused on quality, long-term holdings and is actively marketing to close the discount gap.

Financial highlights

• Annualized management expense ratio rose to 0.53% from 0.46% due to lower refunds.

• Portfolio outperformed the benchmark over 6 months, 1, 5, and 10 years on a grossed-up basis.

• Six-month portfolio return was 8.7%–8.9%, with 10-year annualized return at 10.5%.

• Buyback and DRP neutralization strategies are in place to address the share price discount.

• Cash at period end was $10.4 million.

Outlook and guidance

• Earnings growth is expected to be more challenging amid subdued economic conditions and elevated market valuations.

• Interest rate uncertainty is likely to continue causing volatility; current rates are seen as closer to long-term averages.

• Portfolio maintains liquidity and cash to capitalize on market opportunities.

• Focus remains on quality companies with strong balance sheets and aligned management.

• Corporate earnings outlook for the upcoming reporting season will be closely monitored.